Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients

Diabetes Care

Volumn 29, Issue 11, 2006, Pages 2504-2505

  Ballani, Piya ^a   Tran, Michael T ^a   Navar, Maria D ^a   Davidson, Mayer B ^a,b  

^a KING DREW MEDICAL CENTER   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; WEIGHT CHANGE;

ADULT; ALGORITHMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 33845484461     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1478     Document Type: Article

References (10)

1. Peters Harmel A, Mathur R: Davidson's Diabetes Mellitus: Diagnosis and Treatment. 5th ed. Philadelphia, Elsevier, 2004, p. 133
2. Cochran E, Musso C, Gorden P: The use of U-500 in patients with extreme insulin resistance. Diabetes Care 28:1240-1244, 2005
3. Nathan D, Axelrod L, Flier JS, Carr DB: U-500 insulin in the treatment of antibody-mediated insulin resistance. Ann Intern Med 94:653-656, 1981
4. Dolberg BK, Lenhard MJ: Successful outcome of pregnancy in a patient with generalized lipoatrophic diabetes mellitus. Endocr Pract 6:34 -36, 2000
5. Baumann G, Drobny EC: Enhanced efficacy of U-500 insulin in the treatment of insulin resistance caused by target tissue insensitivity. Am J Med 76:529-532, 1984
6. Knee TS, Seidensticker DF, Walton JL, Solberg LM, Lasseter DH: A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series. Endocr Pract 9:181-186, 2003
7. Neal JM: Analysis of effectiveness of human U-500 insulin in patients unresponsive to conventional insulin therapy. Endocr Pract 11:305-307, 2005
8. Lane WS: Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance. Endocr Pract 12:251-256, 2006
9. Wafa WS, Khan MI: Use of U-500 regular insulin in type 2 diabetes (Letter). Diabetes Care 29:2175, 2006
10. Jorgensen KH, Hansen AK, Buschard K: Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs. Diabetes Res Clin Pract 50:161-167, 2000